Home › Marginal Zone Lymphoma › Virginia › Richmond
Marginal Zone Lymphoma clinical trials in Richmond, VA
3 studies for Marginal Zone Lymphoma are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecruitingPhase 1/2
- Virginia Commonwealth University Massey Cancer Center, Richmond
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
RecruitingPhase 2
- VCU Massey Comprehensive Cancer Center, Richmond
A Study of ARC-02 in B-cell NHL
RecruitingPhase 1
- Massey Cancer Center, Richmond
Marginal Zone Lymphoma trials in other cities
- Durham, NC12 studies
- New York City, NY11 studies
- Baldwin Park, CA9 studies
- Seattle, WA9 studies
- Boston, MA9 studies
- Milwaukee, WI9 studies
- Columbus, OH8 studies
- Rochester, MN8 studies
- Edison, NJ8 studies
- Houston, TX8 studies
- Denver, CO7 studies
- Miami, FL7 studies
Other studies in Richmond
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer25 studies
- Prostate Cancer19 studies
- Heart Failure16 studies
- Lung Cancer14 studies
- Cardiovascular Disease13 studies
- Colorectal Cancer13 studies
- Steatotic Liver Disease12 studies
- Acute Myeloid Leukemia12 studies
- Metastatic Cancer12 studies
- Head and Neck Squamous Cell Carcinoma12 studies
- Obesity11 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.